Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TSSK 2 Inhibitors

TSSK2 inhibitors belong to a specialized chemical class of compounds designed to specifically target and inhibit the activity of TSSK2 (Testis-specific serine/threonine-protein kinase 2). TSSK2 is a protein kinase primarily expressed in the testis and plays a crucial role in spermatogenesis, the process of sperm cell development. The inhibition of TSSK2 activity is of significant interest in the field of reproductive biology, as it offers insights into male fertility and reproductive health. The design of TSSK2 inhibitors involves a careful combination of chemistry approaches, computational modeling, and structural analysis. Researchers aim to create compounds that possess high selectivity and affinity for TSSK2, minimizing potential cross-reactivity with other kinases or cellular targets. This specificity ensures that the inhibitors effectively block the enzymatic activity of TSSK2 without interfering with unrelated pathways or cellular functions.

In laboratory settings, TSSK2 inhibitors serve as essential tools for research studies focused on understanding the role of TSSK2 in spermatogenesis. Additionally, these inhibitors facilitate a deeper understanding of the molecular mechanisms and signaling pathways regulated by TSSK2, shedding light on the intricacies of male reproductive biology. The class of TSSK2 inhibitors comprises diverse chemical compounds, each with unique structural features and properties. Researchers utilize various strategies to optimize the inhibitory potency and selectivity of these compounds, aiming to expand their utility as research tools in the field of reproductive science. It is crucial to emphasize that the biological activity and specificity of TSSK2 inhibitors may vary, and further research is necessary to fully characterize their efficacy and potential applications.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SRPIN 340

218156-96-8sc-394310
10 mg
$226.00
1
(1)

Originally identified as a splicing inhibitor, SRPIN 340 also has inhibitory effects on TSSK2.